Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: Improvement in diagnostic sensitivity

Urology

Volumn 57, Issue 6, 2001, Pages 1059-1062

  De Dominicis, C ^a   Liberti, M ^a   Perugia, G ^a   De Nunzio, C ^a   Sciobica, F ^a   Zuccala A ^a   Sarkozy, A ^a   Iori, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER THERAPY; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADULT; AGED; AMINOLEVULINIC ACID; CARCINOMA IN SITU; CYSTOSCOPY; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0035010373     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)00948-7     Document Type: Article

References (15)

1. Schamhart D.H.J., de Reijke T.M., Schalken J.A., et al. The Bard® BTA test its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer. Eur Urol. 34:1998;99-106.
2. Eleuteri P., Grollino M.G., De Vita R., et al. Bladder transitional cell carcinomas a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analysis. Eur Urol. 37:2000;275-280.
3. Desgrippes A., Izadifar J., Beurton D., et al. Diagnosis and prediction of recurrence and progression in superficial bladder cancers with DNA image cytometry and urinary cytology. BJU Int. 85:2000;434-436.
4. Lipson R.L., Baldes E.J. The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol. 82:1960;508-511.
5. Benson R.C. Treatment of bladder cancer with hematoporphyrin derivatives and laser light. Urology. 31:(suppl):1998;13-17.
6. Fukui I., Yokokawa G. In vivo staining test with methylene blue for bladder cancer. J Urol. 130:1983;252-255.
7. Kriegmair M., Baumgartner R., Knüchel R., et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology. 44:1994;836-841.
8. Steinbach P., Kriegmair M., Baumgartner R., et al. Intravesical instillation of 5-aminolevulinic acid the fluorescent metabolite is limited to urothelial cells. Urology. 44:1994;676-681.
9. Kriegmair M., Baumgartner R. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol. 155:1995;105-109.
10. Kriegmair M., Stepp H., Steinbach P., et al. Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid a new procedure with high sensitivity for detection of hardly visible urothelial neoplasms. Urol Int. 55:1995;190-196.
11. De Dominicis C., Liberti M., Perugia G., et al. Role of 5 aminolevulinic acid in the diagnosis and treatment of bladder neoplasias first experience in Italy. Eur Urol. 35:(suppl 2):1999;129.
12. Smith G., Elton R.A., Hargreave T.B., et al. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. BJU Int. 55:1983;665-669.
13. Filbeck T., Roessler W., Knuechel R., et al. Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolaevulinic acid. J Endourol. 13:1999;117-121.
14. Jichlinski P., Wagnières G., Forrer M., et al. Clinical value of fluorescence cystoscopy in the detection of superficial transitional cell carcinoma of the bladder. Ann Urol. 31:1997;43-47.
15. Kriegmair M., Zakk D., Stepp H., et al. Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy. Eur Urol. 36:1999;386-392.